Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia

PURPOSE: Cytogenetically normal (CN) acute myeloid leukemia (AML) is the largest and most heterogeneous cytogenetic AML subgroup. For the practicing clinician, it is difficult to summarize the prognostic information of the growing number of clinical and molecular markers. Our purpose was to develop...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Pastore, Friederike, Dufour, Annika, Benthaus, Tobias, Metzeler, Klaus H., Maharry, Kati S., Schneider, Stephanie, Ksienzyk, Bianka, Mellert, Gudrun, Zellmeier, Evelyn, Kakadia, Purvi M., Unterhalt, Michael, Feuring-Buske, Michaela, Buske, Christian, Braess, Jan, Sauerland, Maria Cristina, Heinecke, Achim, Krug, Utz, Berdel, Wolfgang E., Buechner, Thomas, Woermann, Bernhard, Hiddemann, Wolfgang, Bohlander, Stefan K., Marcucci, Guido, Spiekermann, Karsten, Bloomfield, Clara D., Hoster, Eva
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2014
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876345/
https://ncbi.nlm.nih.gov/pubmed/24711548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.52.3480
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki